Discovery of a Lead Brain‐Penetrating Gonadotropin‐Releasing Hormone Receptor Antagonist with Saturable Binding in Brain
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Discovery of a Lead Brain‐Penetrating Gonadotropin‐Releasing Hormone Receptor Antagonist with Saturable Binding in Brain ; volume:15 ; number:17 ; year:2020 ; pages:1624-1628 ; extent:5
ChemMedChem ; 15, Heft 17 (2020), 1624-1628 (gesamt 5)
- Creator
-
Bekker, Roberto B. W.
Fjellaksel, Richard
Hjornevik, Trine
Nuruddin, Syed
Rafique, Waqas
Hansen, Jørn H.
Sundset, Rune
Haraldsen, Ira H.
Riss, Patrick J.
- DOI
-
10.1002/cmdc.202000256
- URN
-
urn:nbn:de:101:1-2022062807255776167675
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bekker, Roberto B. W.
- Fjellaksel, Richard
- Hjornevik, Trine
- Nuruddin, Syed
- Rafique, Waqas
- Hansen, Jørn H.
- Sundset, Rune
- Haraldsen, Ira H.
- Riss, Patrick J.
Other Objects (12)
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
First in vivo evaluation of a potential SPECT brain radiotracer for the gonadotropin releasing hormone receptor
Early administration of gonadotropin-releasing hormone antagonist versus flexible antagonist ovarian stimulation protocol in poor responders: a randomized clinical trial
Untersuchungen zur Standardisierung von Gonadotropin-Releasing-Aktivität
Gonadotropin-Releasing Hormon- und Gonadotropin-Therapie beim Hypogonadismus des Mannes : ein Therapie-Vergleich
Östrogeneinfluss auf den Gonadotropin-Releasing-Hormonstoffwechsel des Menschen
Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
First in vivo evaluation of a potential SPECT brain radiotracer for the gonadotropin releasing hormone receptor
Early administration of gonadotropin-releasing hormone antagonist versus flexible antagonist ovarian stimulation protocol in poor responders: a randomized clinical trial
Untersuchungen zur Standardisierung von Gonadotropin-Releasing-Aktivität
Gonadotropin-Releasing Hormon- und Gonadotropin-Therapie beim Hypogonadismus des Mannes : ein Therapie-Vergleich
Östrogeneinfluss auf den Gonadotropin-Releasing-Hormonstoffwechsel des Menschen
Comparison of recombinant and urinary follicle-stimulating hormones over 2000 gonadotropin-releasing hormone antagonist cycles: a retrospective study
A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
Clinical Pharmacology of Elagolix: An Oral Gonadotropin-Releasing Hormone Receptor Antagonist for Endometriosis
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
Expression von Gonadotropin-Releasing-Hormon und Gonadotropin-Releasing-Hormon-Rezeptor in Endometriose-Gewebe
A change from gonadotropin releasing hormone antagonist to gonadotropin releasing hormone agonist therapy does not affect the oncological outcomes in hormone sensitive prostate cancer
A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients
First in vivo evaluation of a potential SPECT brain radiotracer for the gonadotropin releasing hormone receptor
Early administration of gonadotropin-releasing hormone antagonist versus flexible antagonist ovarian stimulation protocol in poor responders: a randomized clinical trial
Untersuchungen zur Standardisierung von Gonadotropin-Releasing-Aktivität
Gonadotropin-Releasing Hormon- und Gonadotropin-Therapie beim Hypogonadismus des Mannes : ein Therapie-Vergleich
Östrogeneinfluss auf den Gonadotropin-Releasing-Hormonstoffwechsel des Menschen